Clinical significance of high monocyte counts for the continuous treatment with nintedanib

Clinical significance of high monocyte counts for the continuous treatment with nintedanib

Abstract Background Nintedanib is now widely used to treat interstitial lung disease (ILD). Adverse events, which occur in not a few patients, make it difficult to continue nintedanib treatment, but the risk factors for adverse events are not well understood. Methods In this retrospective cohort stu...

Full description

Bibliographic Details
Main Authors: Shingo Tsuneyoshi, Yoshiaki Zaizen, Masaki Tominaga, Goushi Matama, Shushi Umemoto, Shuuhei Ohno, Reiko Takaki, Ryo Yano, Kenta Murotani, Masaki Okamoto, Tomoaki Hoshino
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Pulmonary Medicine
Subjects:
Nintedanib
Starting dosage
Monocyte count
Adverse events
Online Access:https://doi.org/10.1186/s12890-023-02536-y

Internet

https://doi.org/10.1186/s12890-023-02536-y

Similar Items